Sign inJoin waitlistJoin the waitlist

EK

Ekta Kapadia

Credentials:

History

Children's National Hospital
2012–2015
Medical School
2008–2012

Research

Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study
The Lancet Oncology · 2021 · 479 citations
Pembrolizumab monotherapy for high-risk non-muscle-invasive bladder cancer without carcinoma in situ and unresponsive to BCG (KEYNOTE-057): a single-arm, multicentre, phase 2 trial
The Lancet Oncology · 2024 · 86 citations
KEYNOTE-676: Phase III study of BCG and pembrolizumab for persistent/recurrent high-risk NMIBC
Future Oncology · 2020 · 78 citations

Ashish Kamat
4 papers
GK
Girish Kulkarni
3 papers
NS
Neal Shore
3 papers
DB
Dean Bajorin
2 papers
Edward Uchio
2 papers
Eric Singer
2 papers
Petros Grivas
2 papers
TF
Tara Frenkl
2 papers
AS
Abhishek Srivastava
1 paper
AB
Arjun Balar
1 paper
BK
Badrinath Konety
1 paper
David Jacobsohn
1 paper